These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 19623659

  • 21. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1.
    Shishodia S, Potdar P, Gairola CG, Aggarwal BB.
    Carcinogenesis; 2003 Jul; 24(7):1269-79. PubMed ID: 12807725
    [Abstract] [Full Text] [Related]

  • 22. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
    Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S, Aggarwal BB.
    Int J Cancer; 2010 Jul 15; 127(2):257-68. PubMed ID: 19908231
    [Abstract] [Full Text] [Related]

  • 23. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
    Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK.
    Clin Cancer Res; 2007 Jun 01; 13(11):3423-30. PubMed ID: 17545551
    [Abstract] [Full Text] [Related]

  • 24. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
    Shi DB, Li XX, Zheng HT, Li DW, Cai GX, Peng JJ, Gu WL, Guan ZQ, Xu Y, Cai SJ.
    Cell Biochem Biophys; 2014 Jul 01; 69(3):523-30. PubMed ID: 24435883
    [Abstract] [Full Text] [Related]

  • 25. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
    Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.
    Int J Cancer; 2012 Aug 01; 131(3):E292-303. PubMed ID: 21935918
    [Abstract] [Full Text] [Related]

  • 26. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers.
    Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM.
    Biochem Pharmacol; 2010 Jan 15; 79(2):218-28. PubMed ID: 19682434
    [Abstract] [Full Text] [Related]

  • 27. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
    Kang HJ, Lee SH, Price JE, Kim LS.
    Breast J; 2009 Jan 15; 15(3):223-9. PubMed ID: 19645775
    [Abstract] [Full Text] [Related]

  • 28. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis.
    Prakobwong S, Khoontawad J, Yongvanit P, Pairojkul C, Hiraku Y, Sithithaworn P, Pinlaor P, Aggarwal BB, Pinlaor S.
    Int J Cancer; 2011 Jul 01; 129(1):88-100. PubMed ID: 20824699
    [Abstract] [Full Text] [Related]

  • 29. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
    Shishodia S, Amin HM, Lai R, Aggarwal BB.
    Biochem Pharmacol; 2005 Sep 01; 70(5):700-13. PubMed ID: 16023083
    [Abstract] [Full Text] [Related]

  • 30. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
    Al-Qasem A, Al-Howail HA, Al-Swailem M, Al-Mazrou A, Al-Otaibi B, Al-Jammaz I, Al-Khalaf HH, Aboussekhra A.
    Mol Carcinog; 2016 Mar 01; 55(3):233-44. PubMed ID: 25641341
    [Abstract] [Full Text] [Related]

  • 31. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL, Wu JG, Dai N, Yu HG, Si JM.
    Oncol Rep; 2011 Nov 01; 26(5):1197-203. PubMed ID: 21811763
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.